The Effect of Virtual Reality Application on Independence and Hand Functions in Daily Life in Children With CP

NCT ID: NCT06317935

Last Updated: 2024-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-23

Study Completion Date

2024-10-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the effect of virtual reality applications on the level of independence and upper extremity functionality perceived by children in daily life in children with hemipegic cerebral palsy.

The research is a randomized controlled, cross-over study. The sample group of the research is children diagnosed with hemiplegic cerebral palsy and families who are receiving inpatient treatment in the pediatric service of Ankara City Hospital Physical Therapy and Rehabilitation Hospital.

Two groups, intervention (A) and control (B), will be created from the target research group using the randomization method.

The upper extremity functionality of both research groups before the intervention will be evaluated with the 'Motor Activity Diary for Children' scale and the perceived independence level with the 'Children's Hand Use Experience' scale.

After the initial evaluation is completed, group A, represented as the intervention group, will receive ArmeoSenso virtual reality intervention in the upper extremity hand function laboratory for 3 weeks, 5 days a week, each session for 30 minutes, in addition to traditional occupational therapy and physiotherapy rehabilitation programs. Meanwhile, group B, represented as the control group, will continue the traditional occupational therapy and physiotherapy rehabilitation program. At the end of the third week of the intervention, tests measuring upper extremity functionality and perceived independence level will be repeated.

Measurement tools will be repeated at the beginning of the intervention, at the end of the 3rd week, and at the end of the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The sample group of the research is children between the ages of 6-12, diagnosed with hemiplegic cerebral palsy, who are receiving inpatient treatment in the pediatric service of Ankara City Hospital Physical Therapy and Rehabilitation Hospital, and their families.

Statistical power analysis was performed to calculate the number of people required to be included in the study. Statistical power analysis was performed with G\*Power v.3.1.9.7 software. In the analysis, the Type 1 error margin (α) was accepted as 5% and the desired statistical power (1-β) was accepted as 0.80. In order to carry out the analysis, randomized controlled studies in the literature on the subject that reported effect sizes were examined. Studies have found that in virtual reality-based interventions applied to children with cerebral palsy, strong to very strong effect sizes were reported between intervention and control groups in variables such as upper extremity functions and performance in daily living activities (4, 7-11). When calculations were made using the strong effect size (Cohen's d = 0.80) in the sample size analysis, it was determined that the smallest sample size that needed to be reached for both groups was 26. Therefore, a total of 52 people were included in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemiplegic Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Two groups, intervention (A) and control (B), will be created from the target research group using the randomization method.

Intervention group (A) will receive virtual reality application for 30 minutes, 5 days a week for 3 weeks, in addition to traditional occupational therapy and physiotherapy approaches for the first 3 weeks, and will receive only traditional treatments between 3-6 weeks.

The control group (B) will receive only traditional occupational therapy and physiotherapy approaches for the first 3 weeks, and between 3-6 weeks, they will receive virtual reality application in addition to traditional approaches for 30 minutes, 5 days a week for 3 weeks.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ArmeoSenso

ArmeoSenso virtual reality application will be applied to group A in the 0-3 weeks of the study and to group B in the 3-6 weeks.

Group Type OTHER

ArmeoSenso

Intervention Type OTHER

ArmeoSenso is an upper extremity virtual reality application with three motion sensors and one hand grip sensor. The device detects the person's body, arm, forearm and hand movements and displays the reflection of the movements on the screen. The application includes studies on upper extremity functions.

Traditional Rehabilitation

Intervention Type OTHER

It includes traditional occupational therapy and physiotherapy approaches.

Traditional rehabilitation

Traditional rehabilitation (physiotherapy and occupational therapy) approaches will continue to be applied to groups A and B at all stages of the research.

Group Type OTHER

Traditional Rehabilitation

Intervention Type OTHER

It includes traditional occupational therapy and physiotherapy approaches.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ArmeoSenso

ArmeoSenso is an upper extremity virtual reality application with three motion sensors and one hand grip sensor. The device detects the person's body, arm, forearm and hand movements and displays the reflection of the movements on the screen. The application includes studies on upper extremity functions.

Intervention Type OTHER

Traditional Rehabilitation

It includes traditional occupational therapy and physiotherapy approaches.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \- Having a diagnosis of hemiplegic SP
* Being between the ages of 6-12
* Not having any fixed contracture in the upper extremity
* According to the Modified Ashworth Scale, the upper extremity spasticity value is at the level of 1,1+,2 or 3
* Being at level I, II or III according to the Gross Motor Function Classification System (GMFCS)
* Being at level II or III according to the Manual Ability Classification System (MACS)
* Being at level I, II or III according to the Communication Function Classification System (CFCS)
* Being within the normal cognitive level according to the Modified Pediatrics Mini Mental Test score
* Being at level I, II or III according to the Eating and Drinking Ability Classification System (EDACS)
* Being at level I, II or III according to the Visual Function Classification System for Children with Cerabral Palsy (VFCS)
* Volunteering to participate in the study

Exclusion Criteria

* Having botolinum toxin injection within the last 6 months
* Having undergone a surgical procedure within the last 1 year
* Fracture, trauma, etc. in the upper extremity. to live
Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ankara City Hospital Bilkent

OTHER

Sponsor Role collaborator

Hacettepe University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Basak Karadag

Occupational Therapist, PhD Student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Başak Karadağ, MSc

Role: PRINCIPAL_INVESTIGATOR

Ankara City Hospital Bilkent

Meral Huri, Professor

Role: STUDY_DIRECTOR

Hacettepe University

Berke Aras, Ass.Prof.

Role: PRINCIPAL_INVESTIGATOR

Ankara City Hospital Bilkent

Özge Tezen, MD

Role: STUDY_CHAIR

Ankara City Hospital Bilkent

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ankara Bilkent City Hospital

Multiple Locations, Ankara, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Başak Karadağ, MSc.

Role: CONTACT

+905059462128

Meral Huri, Professor

Role: CONTACT

+905335515590

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Başak Karadağ, MSc

Role: primary

+905059462128

Berke Aras, Ass. Prof.

Role: backup

+90365851518

References

Explore related publications, articles, or registry entries linked to this study.

Chen YP, Lee SY, Howard AM. Effect of virtual reality on upper extremity function in children with cerebral palsy: a meta-analysis. Pediatr Phys Ther. 2014 Fall;26(3):289-300. doi: 10.1097/PEP.0000000000000046.

Reference Type BACKGROUND
PMID: 24819682 (View on PubMed)

Goyal C, Vardhan V, Naqvi W. Virtual Reality-Based Intervention for Enhancing Upper Extremity Function in Children With Hemiplegic Cerebral Palsy: A Literature Review. Cureus. 2022 Jan 28;14(1):e21693. doi: 10.7759/cureus.21693. eCollection 2022 Jan.

Reference Type BACKGROUND
PMID: 35237486 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HU-ERG-BK-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.